Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
2.480
+0.010 (0.40%)
At close: Jul 10, 2025, 4:00 PM
2.440
-0.040 (-1.61%)
After-hours: Jul 10, 2025, 7:47 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 2019 2016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Chimeric Antigen Receptors T Cell Therapies
1.70M
Log In
Log In
Log In
Log In
Upgrade
Chimeric Antigen Receptors T Cell Therapies Growth
-73.30%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 2019 2016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
United States
1.35M
Log In
Log In
Log In
Log In
Upgrade
United Kingdom
346.00K
Log In
Log In
Log In
Log In
Upgrade
United Kingdom, Europe and United States
-
Log In
Log In
Log In
Log In
Upgrade
United Kingdom, Europe and United States Growth
-
Log In
Log In
Log In
Log In
Upgrade